nach oben

Erschienen in:

01.03.2016 | Original Contribution

Facial emotion perception by intensity in children and adolescents with 22q11.2 deletion syndrome

verfasst von: Arnaud Leleu, Guillaume Saucourt, Caroline Rigard, Gabrielle Chesnoy, Jean-Yves Baudouin, Massimiliano Rossi, Patrick Edery, Nicolas Franck, Caroline Demily

Erschienen in: European Child & Adolescent Psychiatry | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Difficulties in the recognition of emotions in expressive faces have been reported in people with 22q11.2 deletion syndrome (22q11.2DS). However, while low-intensity expressive faces are frequent in everyday life, nothing is known about their ability to perceive facial emotions depending on the intensity of expression. Through a visual matching task, children and adolescents with 22q11.2DS as well as gender- and age-matched healthy participants were asked to categorise the emotion of a target face among six possible expressions. Static pictures of morphs between neutrality and expressions were used to parametrically manipulate the intensity of the target face. In comparison to healthy controls, results showed higher perception thresholds (i.e. a more intense expression is needed to perceive the emotion) and lower accuracy for the most expressive faces indicating reduced categorisation abilities in the 22q11.2DS group. The number of intrusions (i.e. each time an emotion is perceived as another one) and a more gradual perception performance indicated smooth boundaries between emotional categories. Correlational analyses with neuropsychological and clinical measures suggested that reduced visual skills may be associated with impaired categorisation of facial emotions. Overall, the present study indicates greater difficulties for children and adolescents with 22q11.2DS to perceive an emotion in low-intensity expressive faces. This disability is subtended by emotional categories that are not sharply organised. It also suggests that these difficulties may be associated with impaired visual cognition, a hallmark of the cognitive deficits observed in the syndrome. These data yield promising tracks for future experimental and clinical investigations.

Botto LD, May K, Fernhoff PM et al (2003) A population-based study of the 22q11. 2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics 112:101–107CrossRefPubMed

Shprintzen RJ (2008) Velo-cardio-facial syndrome: 30 Years of study. Dev Disabil Res Rev 14:3–10PubMedCentralCrossRefPubMed

Gothelf D, Frisch A, Munitz H et al (1999) Clinical characteristics of schizophrenia associated with velo-cardio-facial syndrome. Schizophr Res 35:105–112. doi:10.1016/S0920-9964(98)00114-5 CrossRefPubMed

Eliez S, Schmitt JE, White CD, Reiss AL (2000) Children and adolescents with velocardiofacial syndrome: a volumetric MRI study. Am J Psychiatry 157:409–415CrossRefPubMed

Simon TJ, Ding L, Bish JP et al (2005) Volumetric, connective, and morphologic changes in the brains of children with chromosome 22q11. 2 deletion syndrome: an integrative study. Neuroimage 25:169–180CrossRefPubMed

Barnea-Goraly N, Eliez S, Menon V et al (2005) Arithmetic ability and parietal alterations: a diffusion tensor imaging study in Velocardiofacial syndrome. Cogn Brain Res 25:735–740. doi:10.1016/j.cogbrainres.2005.09.013 CrossRef

Van Amelsvoort T, Daly E, Robertson D et al (2001) Structural brain abnormalities associated with deletion at chromosome 22q11 Quantitative neuroimaging study of adults with velo-cardio-facial syndrome. Br J Psychiatry 178:412–419. doi:10.1192/bjp.178.5.412 CrossRefPubMed

Eliez S, Schmitt JE, White CD et al (2001) A quantitative MRI study of posterior fossa development in velocardiofacial syndrome. Biol Psychiatry 49:540–546CrossRefPubMed

Eliez S, Barnea-Goraly N, Schmitt JE et al (2002) Increased basal ganglia volumes in velo-cardio-facial syndrome (deletion 22q11. 2). Biol Psychiatry 52:68–70CrossRefPubMed

10.

Kates WR, Burnette CP, Bessette BA et al (2004) Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11. 2). J Child Neurol 19:337–342CrossRefPubMed

11.

Kates WR, Miller AM, Abdulsabur N et al (2006) Temporal lobe anatomy and psychiatric symptoms in velocardiofacial syndrome (22q11. 2 deletion syndrome). J Am Acad Child Adolesc Psychiatry 45:587–595CrossRefPubMed

12.

Campbell LE, Daly E, Toal F et al (2006) Brain and behaviour in children with 22q11. 2 deletion syndrome: a volumetric and voxel-based morphometry MRI study. Brain 129:1218–1228CrossRefPubMed

13.

Schaer M, Eric Schmitt J, Glaser B et al (2006) Abnormal patterns of cortical gyrification in velo-cardio-facial syndrome (deletion 22q11.2): an MRI study. Psychiatry Res Neuroimaging 146:1–11. doi:10.1016/j.pscychresns.2005.10.002 CrossRefPubMed

14.

Gothelf D, Penniman L, Gu E et al (2007) Developmental trajectories of brain structure in adolescents with 22q11.2 deletion syndrome: a longitudinal study. Schizophr Res 96:72–81. doi:10.1016/j.schres.2007.07.021 PubMedCentralCrossRefPubMed

15.

Dufour F, Schaer M, Debbané M et al (2008) Cingulate gyral reductions are related to low executive functioning and psychotic symptoms in 22q11.2 deletion syndrome. Neuropsychologia 46:2986–2992. doi:10.1016/j.neuropsychologia.2008.06.012 CrossRefPubMed

16.

Bearden CE, van Erp TGM, Dutton RA et al (2009) Alterations in midline cortical thickness and gyrification patterns mapped in children with 22q11.2 deletions. Cereb Cortex 19:115–126. doi:10.1093/cercor/bhn064 PubMedCentralCrossRefPubMed

17.

Flahault A, Schaer M, Ottet M-C et al (2012) Hippocampal volume reduction in chromosome 22q11.2 deletion syndrome (22q11.2DS): a longitudinal study of morphometry and symptomatology. Psychiatry Res Neuroimaging 203:1–5. doi:10.1016/j.pscychresns.2011.09.003 CrossRefPubMed

18.

Jansen PW, Duijff SN, Beemer FA et al (2007) Behavioral problems in relation to intelligence in children with 22q11. 2 deletion syndrome: a matched control study. Am J Med Genet A 143:574–580CrossRef

19.

Niklasson L, Rasmussen P, Óskarsdóttir S, Gillberg C (2001) Neuropsychiatric disorders in the 22q11 deletion syndrome. Genet Med 3:79–84. doi:10.1097/00125817-200101000-00017 CrossRefPubMed

20.

Shprintzen RJ (2000) Velo-cardio-facial syndrome: a distinctive behavioral phenotype. Ment Retard Dev Disabil Res Rev 6:142–147CrossRefPubMed

21.

Swillen A, Vandeputte L, Cracco J et al (1999) Neuropsychological, learning and psychosocial profile of primary school aged children with the velo-cardio-facial syndrome (22q11 deletion): evidence for a nonverbal learning disability? Child Neuropsychol 5:230–241. doi:10.1076/0929-7049(199912)05:04;1-R;FT230 CrossRefPubMed

22.

Woodin M, Wang PP, Aleman D et al (2001) Neuropsychological profile of children and adolescents with the 22q11.2 microdeletion. Genet Med 3:34–39. doi:10.1097/00125817-200101000-00008 CrossRefPubMed

23.

Eliez S, Palacio-Espasa F, Spira A et al (2000) Young children with Velo-Cardio-Facial syndrome (CATCH-22). Psychological and language phenotypes. Eur Child Adolesc Psychiatry 9:109–114. doi:10.1007/s007870050005 CrossRefPubMed

24.

Swillen A, Vogels A, Devriendt K, Fryns J-P (2000) Chromosome 22q11 deletion syndrome: update and review of the clinical features, cognitive-behavioral spectrum, and psychiatric complications. Am J Med Genet 97:128–135CrossRefPubMed

25.

Feinstein C, Eliez S, Blasey C, Reiss AL (2002) Psychiatric disorders and behavioral problems in children with velocardiofacial syndrome: usefulness as phenotypic indicators of schizophrenia risk. Biol Psychiatry 51:312–318CrossRefPubMed

26.

Antshel KM, Fremont W, Roizen NJ et al (2006) ADHD, major depressive disorder, and simple phobias are prevalent psychiatric conditions in youth with velocardiofacial syndrome. J Am Acad Child Adolesc Psychiatry 45:596–603CrossRefPubMed

27.

Green T, Gothelf D, Glaser B et al (2009) Psychiatric disorders and intellectual functioning throughout development in velocardiofacial (22q11.2 deletion) syndrome. J Am Acad Child Adolesc Psychiatry 48:1060–1068. doi:10.1097/CHI.0b013e3181b76683 CrossRefPubMed

28.

Fabbro A, Rizzi E, Schneider M et al (2012) Depression and anxiety disorders in children and adolescents with velo-cardio-facial syndrome (VCFS). Eur Child Adolesc Psychiatry 21:379–385. doi:10.1007/s00787-012-0273-x CrossRefPubMed

29.

Jolin EM, Weller RA, Weller EB (2012) Occurrence of affective disorders compared to other psychiatric disorders in children and adolescents with 22q11. 2 deletion syndrome. J Affect Disord 136:222–228CrossRefPubMed

30.

Shashi V, Veerapandiyan A, Schoch K et al (2012) Social skills and associated psychopathology in children with chromosome 22q11. 2 deletion syndrome: implications for interventions. J Intellect Disabil Res 56:865–878CrossRefPubMed

31.

Fine SE, Weissman A, Gerdes M et al (2005) Autism spectrum disorders and symptoms in children with molecularly confirmed 22q11. 2 deletion syndrome. J Autism Dev Disord 35:461–470PubMedCentralCrossRefPubMed

32.

Vorstman JA, Morcus ME, Duijff SN et al (2006) The 22q11. 2 deletion in children: high rate of autistic disorders and early onset of psychotic symptoms. J Am Acad Child Adolesc Psychiatry 45:1104–1113CrossRefPubMed

33.

Antshel KM, Aneja A, Strunge L et al (2007) Autistic spectrum disorders in velo-cardio facial syndrome (22q11. 2 deletion). J Autism Dev Disord 37:1776–1786CrossRefPubMed

34.

Murphy KC (2002) Schizophrenia and velo-cardio-facial syndrome. Lancet 359:426–430CrossRefPubMed

35.

Baker KD, Skuse DH (2005) Adolescents and young adults with 22q11 deletion syndrome: psychopathology in an at-risk group. Br J Psychiatry 186:115–120CrossRefPubMed

36.

Jalbrzikowski M, Carter C, Senturk D et al (2012) Social cognition in 22q11.2 microdeletion syndrome: relevance to psychosis? Schizophr Res 142:99–107. doi:10.1016/j.schres.2012.10.007 PubMedCentralCrossRefPubMed

37.

Schneider M, Schaer M, Mutlu AK et al (2014) Clinical and cognitive risk factors for psychotic symptoms in 22q11.2 deletion syndrome: a transversal and longitudinal approach. Eur Child Adolesc Psychiatry 23:425–436. doi:10.1007/s00787-013-0469-8 PubMedCentralCrossRefPubMed

38.

Tang SX, Yi JJ, Calkins ME et al (2014) Psychiatric disorders in 22q11. 2 deletion syndrome are prevalent but undertreated. Psychol Med 44:1267–1277PubMedCentralCrossRefPubMed

39.

Debbané M, Glaser B, David MK et al (2006) Psychotic symptoms in children and adolescents with 22q11.2 deletion syndrome: neuropsychological and behavioral implications. Schizophr Res 84:187–193. doi:10.1016/j.schres.2006.01.019 CrossRefPubMed

40.

Gothelf D, Feinstein C, Thompson T et al (2007) Risk factors for the emergence of psychotic disorders in adolescents with 22q11. 2 deletion syndrome. Am J Psychiatry 164:663–669CrossRefPubMed

41.

Stoddard J, Niendam T, Hendren R et al (2010) Attenuated positive symptoms of psychosis in adolescents with chromosome 22q11.2 deletion syndrome. Schizophr Res 118:118–121. doi:10.1016/j.schres.2009.12.011 PubMedCentralCrossRefPubMed

42.

Schneider M, Van der Linden M, Glaser B et al (2012) Preliminary structure and predictive value of attenuated negative symptoms in 22q11. 2 deletion syndrome. Psychiatry Res 196:277–284CrossRefPubMed

43.

Murphy KC (2005) Annotation: velo-cardio-facial syndrome. J Child Psychol Psychiatry 46:563–571. doi:10.1111/j.1469-7610.2005.00408.x CrossRefPubMed

44.

Karayiorgou M, Simon TJ, Gogos JA (2010) 22q11. 2 microdeletions: linking DNA structural variation to brain dysfunction and schizophrenia. Nat Rev Neurosci 11:402–416PubMedCentralCrossRefPubMed

45.

Xu B, Roos JL, Levy S et al (2008) Strong association of de novo copy number mutations with sporadic schizophrenia. Nat Genet 40:880–885CrossRefPubMed

46.

Bassett AS, Scherer SW, Brzustowicz LM (2010) Copy number variations in schizophrenia: critical review and new perspectives on concepts of genetics and disease. Am J Psychiatry 167:899–914. doi:10.1176/appi.ajp.2009.09071016 PubMedCentralCrossRefPubMed

47.

Bassett AS, Chow EW, AbdelMalik P et al (2003) The schizophrenia phenotype in 22q11 deletion syndrome. Am J Psychiatry 160:1580–1586PubMedCentralCrossRefPubMed

48.

Monks S, Niarchou M, Davies AR et al (2014) Further evidence for high rates of schizophrenia in 22q11.2 deletion syndrome. Schizophr Res 153:231–236. doi:10.1016/j.schres.2014.01.020 CrossRefPubMed

49.

Henry JC, Van Amelsvoort T, Morris RG et al (2002) An investigation of the neuropsychological profile in adults with velo-cardio-facial syndrome (VCFS). Neuropsychologia 40:471–478CrossRefPubMed

50.

Lajiness-O’Neill RR, Beaulieu I, Titus JB et al (2005) Memory and learning in children with 22q11.2 deletion syndrome: evidence for ventral and dorsal stream disruption? Child Neuropsychol 11:55–71. doi:10.1080/09297040590911202 CrossRefPubMed

51.

Lewandowski KE, Shashi V, Berry PM, Kwapil TR (2007) Schizophrenic-like neurocognitive deficits in children and adolescents with 22q11 deletion syndrome. Am J Med Genet B Neuropsychiatr Genet 144:27–36CrossRef

52.

Swillen A, Devriendt K, Legius E et al (1997) Intelligence and psychosocial adjustment in velocardiofacial syndrome: a study of 37 children and adolescents with VCFS. J Med Genet 34:453–458PubMedCentralCrossRefPubMed

53.

Moss EM, Batshaw ML, Solot CB et al (1999) Psychoeducational profile of the 22q11. 2 microdeletion: a complex pattern. J Pediatr 134:193–198CrossRefPubMed

54.

Bearden CE, Woodin MF, Wang PP et al (2001) The neurocognitive phenotype of the 22q11. 2 deletion syndrome: selective deficit in visual-spatial memory. J Clin Exp Neuropsychol 23:447–464CrossRefPubMed

55.

De Smedt B, Devriendt K, Fryns J-P et al (2007) Intellectual abilities in a large sample of children with Velo–Cardio–facial syndrome: an update. J Intellect Disabil Res 51:666–670CrossRefPubMed

56.

Sobin C, Kiley-Brabeck K, Daniels S et al (2005) Neuropsychological characteristics of children with the 22q11 deletion syndrome: a descriptive analysis. Child Neuropsychol 11:39–53PubMedCentralCrossRefPubMed

57.

Simon TJ (2008) A new account of the neurocognitive foundations of impairments in space, time, and number processing in children with chromosome 22q11.2 deletion syndrome. Dev Disabil Res Rev 14:52–58. doi:10.1002/ddrr.8 PubMedCentralCrossRefPubMed

58.

Eliez S, Blasey CM, Schmitt EJ et al (2001) Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia? Am J Psychiatry 158:447–453CrossRefPubMed

59.

Gothelf D, Schaer M, Eliez S (2008) Genes, brain development and psychiatric phenotypes in velo-cardio-facial syndrome. Dev Disabil Res Rev 14:59–68. doi:10.1002/ddrr.9 CrossRefPubMed

60.

Schaer M, Debbané M, Bach Cuadra M et al (2009) Deviant trajectories of cortical maturation in 22q11.2 deletion syndrome (22q11DS): a cross-sectional and longitudinal study. Schizophr Res 115:182–190. doi:10.1016/j.schres.2009.09.016 CrossRefPubMed

61.

Debbané M, Lazouret M, Lagioia A et al (2012) Resting-state networks in adolescents with 22q11.2 deletion syndrome: associations with prodromal symptoms and executive functions. Schizophr Res 139:33–39. doi:10.1016/j.schres.2012.05.021 CrossRefPubMed

62.

McCabe K, Rich D, Loughland CM et al (2011) Visual scanpath abnormalities in 22q11.2 deletion syndrome: is this a face specific deficit? Psychiatry Res 189:292–298. doi:10.1016/j.psychres.2011.06.012 CrossRefPubMed

63.

Campbell LE, Stevens AF, McCabe K et al (2011) Is theory of mind related to social dysfunction and emotional problems in 22q11.2 deletion syndrome (velo-cardio-facial syndrome)? J Neurodev Disord 3:152–161. doi:10.1007/s11689-011-9082-7 PubMedCentralCrossRefPubMed

64.

Campbell L, McCabe K, Leadbeater K et al (2010) Visual scanning of faces in 22q11.2 deletion syndrome: attention to the mouth or the eyes? Psychiatry Res 177:211–215. doi:10.1016/j.psychres.2009.06.007 CrossRefPubMed

65.

McCabe KL, Melville JL, Rich D et al (2013) Divergent patterns of social cognition performance in autism and 22q11. 2 deletion syndrome (22q11DS). J Autism Dev Disord 43:1926–1934CrossRefPubMed

66.

Glaser B, Debbané M, Ottet M-C et al (2010) Eye gaze during face processing in children and adolescents with 22q11. 2 deletion syndrome. J Am Acad Child Adolesc Psychiatry 49:665–674PubMed

67.

Haxby JV, Hoffman EA, Gobbini MI (2000) The distributed human neural system for face perception. Trends Cogn Sci 4:223–233CrossRefPubMed

68.

Glaser B, Schaer M, Berney S et al (2007) Structural changes to the fusiform gyrus: a cerebral marker for social impairments in 22q11.2 deletion syndrome? Schizophr Res 96:82–86. doi:10.1016/j.schres.2007.08.016 CrossRefPubMed

69.

Van Amelsvoort T, Schmitz N, Daly E et al (2006) Processing facial emotions in adults with velo-cardio-facial syndrome: functional magnetic resonance imaging. Br J Psychiatry 189:560–561. doi:10.1192/bjp.bp.105.019876 CrossRefPubMed

70.

Andersson F, Glaser B, Spiridon M et al (2008) Impaired activation of face processing networks revealed by functional magnetic resonance imaging in 22q11.2 deletion syndrome. Biol Psychiatry 63:49–57. doi:10.1016/j.biopsych.2007.02.022 CrossRefPubMed

71.

Ekman P, Friesen WV, Ellsworth P (1972) Emotion in the human face: guidelines for research and an integration of findings. Pergamon Press, Oxford

72.

Etcoff NL, Magee JJ (1992) Categorical perception of facial expressions. Cognition 44:227–240CrossRefPubMed

73.

Calder AJ, Young AW, Perrett DI et al (1996) Categorical perception of morphed facial expressions. Vis Cogn 3:81–118CrossRef

74.

Young AW, Rowland D, Calder AJ et al (1997) Facial expression megamix: tests of dimensional and category accounts of emotion recognition. Cognition 63:271–313CrossRefPubMed

75.

Schneider M, Van der Linden M, Menghetti S et al (2014) Predominant negative symptoms in 22q11.2 deletion syndrome and their associations with cognitive functioning and functional outcome. J Psychiatr Res 48:86–93. doi:10.1016/j.jpsychires.2013.10.010 CrossRefPubMed

76.

Baudouin J-Y, Martin F, Tiberghien G et al (2002) Selective attention to facial emotion and identity in schizophrenia. Neuropsychologia 40:503–511CrossRefPubMed

77.

Martin F, Baudouin J-Y, Tiberghien G, Franck N (2005) Processing emotional expression and facial identity in schizophrenia. Psychiatry Res 134:43–53. doi:10.1016/j.psychres.2003.12.031 CrossRefPubMed

78.

Kay SR, Flszbein A, Opfer LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13:261CrossRefPubMed

79.

Wechsler D (2005) WISC IV—Echelle d’intelligence de Wechsler pour enfants et adolescents—Quatrième Edition. ECPA, Paris

80.

Weschler D (2011) WAIS IV—Nouvelle version de l’échelle d’intelligence de Wechsler pour adultes—Quatrième édition. ECPA, Paris

81.

Wechsler D (2001) MEM-III: Echelle clinique de mémoire de Wechsler—Troisième édition. ECPA, Paris

82.

Wallon P, Mesmin C (2009) Test de la figure complexe de Rey. ECPA, Paris

83.

Benton AL, Hamsher KD, Varney NR, Spreen O (1983) Judgment of line orientation. Oxford University Press, New York

84.

Brickenkamp R (1998) Test d’attention concentrée-d2. ECPA, Paris

85.

Chambon V, Baudouin J-Y, Franck N (2006) The role of configural information in facial emotion recognition in schizophrenia. Neuropsychologia 44:2437–2444CrossRefPubMed

86.

Durand K, Gallay M, Seigneuric A et al (2007) The development of facial emotion recognition: the role of configural information. J Exp Child Psychol 97:14–27CrossRefPubMed

87.

Kim H, Somerville LH, Johnstone T et al (2003) Inverse amygdala and medial prefrontal cortex responses to surprised faces. NeuroReport 14:2317–2322CrossRefPubMed

88.

Kim H, Somerville L, Johnstone T et al (2004) Contextual modulation of amygdala responsivity to surprised faces. J Cogn Neurosci 16:1730–1745CrossRefPubMed

89.

Vernet M, Baudouin J-Y, Franck N (2008) Facial emotion space in schizophrenia. Cognit Neuropsychiatry 13:59–73. doi:10.1080/13546800701795228 CrossRef

90.

Giersch A, Glaser B, Pasca C et al (2014) Individuals with 22q11.2 deletion syndrome are impaired at explicit, but not implicit, discrimination of local forms embedded in global structures. Am J Intellect Dev Disabil 119:261–275. doi:10.1352/1944-7558-119.3.261 CrossRefPubMed

91.

Antshel KM, Peebles J, AbdulSabur N et al (2008) Associations between performance on the Rey–Osterrieth Complex Figure and regional brain volumes in children with and without velocardiofacial syndrome. Dev Neuropsychol 33:601–622PubMedCentralCrossRefPubMed

92.

Todd JJ, Marois R (2004) Capacity limit of visual short-term memory in human posterior parietal cortex. Nature 428:751–754. doi:10.1038/nature02466 CrossRefPubMed

93.

Kiley-Brabeck K, Sobin C (2006) Social skills and executive function deficits in children with the 22q11 deletion syndrome. Appl Neuropsychol 13:258–268PubMedCentralCrossRefPubMed

94.

Ochsner KN (2008) The social-emotional processing stream: five core constructs and their translational potential for schizophrenia and beyond. Biol Psychiatry 64:48–61. doi:10.1016/j.biopsych.2008.04.024 PubMedCentralCrossRefPubMed

95.

Demily C, Weiss T, Desmurget M et al (2011) Recognition of self-generated facial emotions is impaired in schizophrenia. J Neuropsychiatry Clin Neurosci 23:189–193CrossRefPubMed

Titel: Facial emotion perception by intensity in children and adolescents with 22q11.2 deletion syndrome
verfasst von: Arnaud Leleu
Guillaume Saucourt
Caroline Rigard
Gabrielle Chesnoy
Jean-Yves Baudouin
Massimiliano Rossi
Patrick Edery
Nicolas Franck
Caroline Demily
Publikationsdatum: 01.03.2016
Verlag: Springer Berlin Heidelberg
Erschienen in: European Child & Adolescent Psychiatry / Ausgabe 3/2016
Print ISSN: 1018-8827
Elektronische ISSN: 1435-165X
DOI: https://doi.org/10.1007/s00787-015-0741-1

Neu im Fachgebiet Psychiatrie

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Weniger postpartale Depressionen nach Esketamin-Einmalgabe

23.04.2024 Depression antepartal oder postpartal Nachrichten

Bislang gibt es kein Medikament zur Prävention von Wochenbettdepressionen. Das Injektionsanästhetikum Esketamin könnte womöglich diese Lücke füllen.

„Psychotherapie ist auch bei sehr alten Menschen hochwirksam!“

22.04.2024 DGIM 2024 Kongressbericht

Die Kombination aus Medikamenten und Psychotherapie gilt als effektivster Ansatz bei Depressionen. Das ist bei betagten Menschen nicht anders, trotz Besonderheiten.

Auf diese Krankheiten bei Geflüchteten sollten Sie vorbereitet sein

22.04.2024 DGIM 2024 Nachrichten

Um Menschen nach der Flucht aus einem Krisengebiet bestmöglich medizinisch betreuen zu können, ist es gut zu wissen, welche Erkrankungen im jeweiligen Herkunftsland häufig sind. Dabei hilft eine Internetseite der CDC (Centers for Disease Control and Prevention).

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

Decreasing ADHD phenotypic heterogeneity: searching for neurobiological underpinnings of the restrictive inattentive phenotype

Emotional face recognition in adolescent suicide attempters and adolescents engaging in non-suicidal self-injury

Disruptive mood dysregulation disorder in ICD-11: a new disorder or ODD with a specifier for chronic irritability?

Health-related quality of life of children with attention-deficit/hyperactivity disorder versus children with diabetes and healthy controls